Stem Cell-Based Therapies for Cancer

被引：11

作者：

Bhere, Deepak ^{[1
]}

Shah, Khalid ^{[1
]}

机构：

[1] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02215 USA

来源：

ADVANCES IN CANCER RESEARCH, VOL 127 | 2015年 / 127卷

关键词：

APOPTOSIS-INDUCING LIGAND; MESENCHYMAL PROGENITOR CELLS; EGF RECEPTOR TRANSACTIVATION; LUNG METASTASIS MODEL; BONE-MARROW; IN-VITRO; OVARIAN-CANCER; BRAIN-TUMORS; GENE-THERAPY; TARGETED-DELIVERY;

D O I：

10.1016/bs.acr.2015.04.012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Stem cell-based therapeutic strategies have emerged as very attractive treatment options over the past decade. Stem cells are now being utilized as delivery vehicles especially in cancer therapy to deliver a number of targeted proteins and viruses. This chapter aims to shed light on numerous studies that have successfully employed these strategies to target various cancer types with a special emphasis on numerous aspects that are critical to the success of future stem cell-based therapies for cancer.

引用

页码：159 / 189

页数：31

共 143 条

[31] Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma [J].

Gao, Peng ;

Ding, Qiang ;

Wu, Zhong ;

Jiang, Haowen ;

Fang, Zujun .

CANCER LETTERS, 2010, 290 (02) :157-166

[32] Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study [J].

Garcia-Castro, J. ;

Alemany, R. ;

Cascallo, M. ;

Martinez-Quintanilla, J. ;

del Mar Arriero, M. ;

Lassaletta, A. ;

Madero, L. ;

Ramirez, M. .

CANCER GENE THERAPY, 2010, 17 (07) :476-483

[33] Mesenchymal stem cells as vehicles for targeted delivery of anti-angiogenic protein to solid tumors [J].

Ghaedi, Mahboobe ;

Soleimani, Masoud ;

Taghvaie, Narges Mohammad ;

Sheikhfatollahi, Mahmood ;

Azadmanesh, Keyhan ;

Lotfi, Abbas S. ;

Wu, Jian .

JOURNAL OF GENE MEDICINE, 2011, 13 (03) :171-180

[34] Human umbilical cord blood stem cells show PDGF-D-dependent glioma cell tropism in vitro and in vivo [J].

Gondi, Christopher S. ;

Veeravalli, Krishna Kumar ;

Gorantla, Bharathi ;

Dinh, Dzung H. ;

Fassett, Dan ;

Klopfenstein, Jeffrey D. ;

Gujrati, Meena ;

Rao, Jasti S. .

NEURO-ONCOLOGY, 2010, 12 (05) :453-465

[35] Interferon and malignant disease -: How does it work and why doesn't it always? [J].

Grandér, D ;

Einhorn, S .

ACTA ONCOLOGICA, 1998, 37 (04) :331-338

[36] Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy [J].

Grisendi, Giulia ;

Bussolari, Rita ;

Cafarelli, Luigi ;

Petak, Istvan ;

Rasini, Valeria ;

Veronesi, Elena ;

De Santis, Giorgio ;

Spano, Carlotta ;

Tagliazzucchi, Mara ;

Barti-Juhasz, Helga ;

Scarabelli, Laura ;

Bambi, Franco ;

Frassoldati, Antonio ;

Rossi, Giulio ;

Casali, Christian ;

Morandi, Uliano ;

Horwitz, Edwin M. ;

Paolucci, Paolo ;

Conte, PierFranco ;

Dominici, Massimo .

CANCER RESEARCH, 2010, 70 (09) :3718-3729

[37] Concise review: Multipotent mesenchymal stromal cells in blood [J].

He, Qiling ;

Wan, Chao ;

Li, Gang .

STEM CELLS, 2007, 25 (01) :69-77

[38]

Hendijani F, 2015, TISSUE CELL

[39] A new role of substance P as an injury-inducible messenger for mobilization of CD29+ stromal-like cells [J].

Hong, Hyun Sook ;

Lee, Jungsun ;

Lee, EunAh ;

Kwon, Young Sam ;

Lee, Eunkyung ;

Ahn, Woosung ;

Jiang, Mei Hua ;

Kim, Jae Chan ;

Son, Youngsook .

NATURE MEDICINE, 2009, 15 (04) :425-435

[40] Tracking normalization of brain tumor vasculature by magnetic imaging and proangiogenic biomarkers [J].

Hormigo, Adilia ;

Gutin, Philip H. ;

Rafii, Shahin .

CANCER CELL, 2007, 11 (01) :6-8

← 1 2 3 4 5 6 7 8 9 10 →